open access

Vol 74, No 3 (2023)
Original paper
Submitted: 2023-01-25
Accepted: 2023-02-25
Published online: 2023-05-04
Get Citation

Leukocyte transcriptome of Cushing’s disease are associated with nerve impairment and psychiatric disorders

Kunyu He12, Tao Zhou1, Fuyu Wang1, Fangye Li1, Yanyang Zhang1, Xinguang Yu1
·
Pubmed: 37155308
·
Endokrynol Pol 2023;74(3):294-304.
Affiliations
  1. Department of Neurosurgery, The First Medical Centre of Chinese PLA General Hospital, Beijing, China
  2. Chinese PLA Medical School, Beijing, China

open access

Vol 74, No 3 (2023)
Original Paper
Submitted: 2023-01-25
Accepted: 2023-02-25
Published online: 2023-05-04

Abstract

Introduction: The hypothalamus-pituitary-adrenal (HPA) axis and its end product cortisol is a major response mechanism to stress and plays a critical role in many psychiatric disorders. Cushing’s disease (CD) serves as a valuable in vivo “hyperexpression” model to elucidate the effect of cortisol on brain function and mental disorders. Changes in brain macroscale properties measured by magnetic resonance imaging (MRI) have been detailed demonstrated, but the biological and molecular mechanisms underlying these changes remain poorly understood.

Material and methods: Here we included 25 CD patients and matched 18 healthy controls for assessment, and performed transcriptome sequencing of peripheral blood leukocytes. Weighted gene co-expression network analysis (WGCNA) was performed to construct a co-expression network of the relationships between genes and we identified a significant module and hub gene types associated with neuropsychological phenotype and psychiatric disorder identified in enrichment analysis. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis preliminarily explored the biological functions of these modules.

Results: The WGCNA and enrichment analysis indicated that module 3 of blood leukocytes was enriched in broadly expressed genes and was associated with neuropsychological phenotypes and mental diseases enrichment. GO and KEGG enrichment analysis of module 3 identified enrichment in many biological pathways associated with psychiatric disorders.

Conclusion: Leukocyte transcriptome of Cushing’s disease is enriched in broadly expressed genes and is associated with nerve impairment and psychiatric disorders, which may reflect some changes in the affected brain.

Abstract

Introduction: The hypothalamus-pituitary-adrenal (HPA) axis and its end product cortisol is a major response mechanism to stress and plays a critical role in many psychiatric disorders. Cushing’s disease (CD) serves as a valuable in vivo “hyperexpression” model to elucidate the effect of cortisol on brain function and mental disorders. Changes in brain macroscale properties measured by magnetic resonance imaging (MRI) have been detailed demonstrated, but the biological and molecular mechanisms underlying these changes remain poorly understood.

Material and methods: Here we included 25 CD patients and matched 18 healthy controls for assessment, and performed transcriptome sequencing of peripheral blood leukocytes. Weighted gene co-expression network analysis (WGCNA) was performed to construct a co-expression network of the relationships between genes and we identified a significant module and hub gene types associated with neuropsychological phenotype and psychiatric disorder identified in enrichment analysis. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis preliminarily explored the biological functions of these modules.

Results: The WGCNA and enrichment analysis indicated that module 3 of blood leukocytes was enriched in broadly expressed genes and was associated with neuropsychological phenotypes and mental diseases enrichment. GO and KEGG enrichment analysis of module 3 identified enrichment in many biological pathways associated with psychiatric disorders.

Conclusion: Leukocyte transcriptome of Cushing’s disease is enriched in broadly expressed genes and is associated with nerve impairment and psychiatric disorders, which may reflect some changes in the affected brain.

Get Citation

Keywords

Cushing syndrome; pituitary ACTH hypersecretion; leukocytes; transcriptome; mental disorders

Supp./Additional Files (2)
Supplementary File — Tables
Download
4MB
Supplementary File
Download
278KB
About this article
Title

Leukocyte transcriptome of Cushing’s disease are associated with nerve impairment and psychiatric disorders

Journal

Endokrynologia Polska

Issue

Vol 74, No 3 (2023)

Article type

Original paper

Pages

294-304

Published online

2023-05-04

Page views

1436

Article views/downloads

345

DOI

10.5603/EP.a2023.0030

Pubmed

37155308

Bibliographic record

Endokrynol Pol 2023;74(3):294-304.

Keywords

Cushing syndrome
pituitary ACTH hypersecretion
leukocytes
transcriptome
mental disorders

Authors

Kunyu He
Tao Zhou
Fuyu Wang
Fangye Li
Yanyang Zhang
Xinguang Yu

References (45)
  1. Holtzman CW, Trotman HD, Goulding SM, et al. Stress and neurodevelopmental processes in the emergence of psychosis. Neuroscience. 2013; 249: 172–191.
  2. Agnew-Blais J, Danese A. Childhood maltreatment and unfavourable clinical outcomes in bipolar disorder: a systematic review and meta-analysis. Lancet Psychiatry. 2016; 3(4): 342–349.
  3. Moreno-Peral P, Conejo-Cerón S, Motrico E, et al. Risk factors for the onset of panic and generalised anxiety disorders in the general adult population: a systematic review of cohort studies. J Affect Disord. 2014; 168: 337–348.
  4. Zorn JV, Schür RR, Boks MP, et al. Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis. Psychoneuroendocrinology. 2017; 77: 25–36.
  5. Heim C, Newport DJ, Mletzko T, et al. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology. 2008; 33(6): 693–710.
  6. León-Carrión J, Atutxa AM, Mangas MA, et al. A clinical profile of memory impairment in humans due to endogenous glucocorticoid excess. Clin Endocrinol (Oxf). 2009; 70(2): 192–200.
  7. Piasecka M, Papakokkinou E, Valassi E, et al. Psychiatric and neurocognitive consequences of endogenous hypercortisolism. J Intern Med. 2020; 288(2): 168–182.
  8. Valli I, Crossley NA, Day F, et al. HPA-axis function and grey matter volume reductions: imaging the diathesis-stress model in individuals at ultra-high risk of psychosis. Transl Psychiatry. 2016; 6(5): e797.
  9. Thai M, Schreiner MW, Mueller BA, et al. Coordination between frontolimbic resting state connectivity and hypothalamic-pituitary-adrenal axis functioning in adolescents with and without depression. Psychoneuroendocrinology. 2021; 125: 105123.
  10. Madsen KS, Jernigan TL, Iversen P, et al. Hypothalamic-pituitary-adrenal axis tonus is associated with hippocampal microstructural asymmetry. Neuroimage. 2012; 63(1): 95–103.
  11. Belleau EL, Treadway MT, Pizzagalli DA. The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology. Biol Psychiatry. 2019; 85(6): 443–453.
  12. Mamdani F, Weber MD, Bunney B, et al. Identification of potential blood biomarkers associated with suicide in major depressive disorder. Transl Psychiatry. 2022; 12(1): 159.
  13. van de Leemput J, Glatt SJ, Tsuang MT. The potential of genetic and gene expression analysis in the diagnosis of neuropsychiatric disorders. Expert Rev Mol Diagn. 2016; 16(6): 677–695.
  14. Rollins B, Martin MV, Morgan L, et al. Analysis of whole genome biomarker expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet. 2010; 153B(4): 919–936.
  15. Witt SH, Sommer WH, Hansson AC, et al. Comparison of gene expression profiles in the blood, hippocampus and prefrontal cortex of rats. In Silico Pharmacol. 2013; 1: 15.
  16. Girgenti MJ, Duman RS. Transcriptome Alterations in Posttraumatic Stress Disorder. Biol Psychiatry. 2018; 83(10): 840–848.
  17. Cattane N, Minelli A, Milanesi E, et al. Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood. PLoS One. 2015; 10(2): e0116686.
  18. Guidotti A, Auta J, Davis JM, et al. Toward the identification of peripheral epigenetic biomarkers of schizophrenia. J Neurogenet. 2014; 28(1-2): 41–52.
  19. Boyle EA, Li YI, Pritchard JK. An Expanded View of Complex Traits: From Polygenic to Omnigenic. Cell. 2017; 169(7): 1177–1186.
  20. Lacroix A, Feelders RA, Stratakis CA, et al. Cushing's syndrome. Lancet. 2015; 386(9996): 913–927.
  21. van der Werff SJA, Andela CD, Nienke Pannekoek J, et al. Widespread reductions of white matter integrity in patients with long-term remission of Cushing's disease. Neuroimage Clin. 2014; 4: 659–667.
  22. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008; 9: 559.
  23. Nieman LK, Biller BMK, Findling JW, et al. Endocrine Society. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015; 100(8): 2807–2831.
  24. Langfelder P, Luo R, Oldham MC, et al. Is my network module preserved and reproducible? PLoS Comput Biol. 2011; 7(1): e1001057.
  25. Lanz TA, Reinhart V, Sheehan MJ, et al. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder. Transl Psychiatry. 2019; 9(1): 151.
  26. Jacobson L. Hypothalamic-pituitary-adrenocortical axis: neuropsychiatric aspects. Compr Physiol. 2014; 4(2): 715–738.
  27. Kravtsova-Ivantsiv Y, Cohen S, Ciechanover A. Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-κB precursor. Adv Exp Med Biol. 2011; 691: 95–106.
  28. Demuro A, Mina E, Kayed R, et al. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem. 2005; 280(17): 17294–17300.
  29. Raynes R, Juarez C, Pomatto LCD, et al. Aging and SKN-1-dependent Loss of 20S Proteasome Adaptation to Oxidative Stress in C. elegans. J Gerontol A Biol Sci Med Sci. 2017; 72(2): 143–151.
  30. Pickering AM, Vojtovich L, Tower J, et al. Oxidative stress adaptation with acute, chronic, and repeated stress. Free Radic Biol Med. 2013; 55: 109–118.
  31. Bousman CA, Chana G, Glatt SJ, et al. Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples. Am J Med Genet B Neuropsychiatr Genet. 2010; 153B(2): 494–502.
  32. Fedoce Ad, Ferreira F, Bota RG, et al. The role of oxidative stress in anxiety disorder: cause or consequence? Free Radic Res. 2018; 52(7): 737–750.
  33. Arion D, Corradi JP, Tang S, et al. Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder. Mol Psychiatry. 2015; 20(11): 1397–1405.
  34. Grune T, Jung T, Merker K, et al. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. Int J Biochem Cell Biol. 2004; 36(12): 2519–2530.
  35. Ding Q, Cecarini V, Keller JN. Interplay between protein synthesis and degradation in the CNS: physiological and pathological implications. Trends Neurosci. 2007; 30(1): 31–36.
  36. Ding Q, Dimayuga E, Markesbery WR, et al. Proteasome inhibition induces reversible impairments in protein synthesis. FASEB J. 2006; 20(8): 1055–1063.
  37. Andela CD, van der Werff SJA, Pannekoek JN, et al. Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing's disease: a case-control study. Eur J Endocrinol. 2013; 169(6): 811–819.
  38. Santos A, Granell E, Gómez-Ansón B, et al. Depression and Anxiety Scores Are Associated with Amygdala Volume in Cushing's Syndrome: Preliminary Study. Biomed Res Int. 2017; 2017: 2061935.
  39. Petschner P, Gonda X, Baksa D, et al. Genes Linking Mitochondrial Function, Cognitive Impairment and Depression are Associated with Endophenotypes Serving Precision Medicine. Neuroscience. 2018; 370: 207–217.
  40. Ben-Shachar D. The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia. J Neural Transm (Vienna). 2009; 116(11): 1383–1396.
  41. Gonçalves VF, Giamberardino SN, Crowley JJ, et al. Examining the role of common and rare mitochondrial variants in schizophrenia. PLoS One. 2018; 13(1): e0191153.
  42. Jeong H, Dimick MK, Sultan A, et al. Peripheral biomarkers of mitochondrial dysfunction in adolescents with bipolar disorder. J Psychiatr Res. 2020; 123: 187–193.
  43. Marazziti D, Baroni S, Picchetti M, et al. Psychiatric disorders and mitochondrial dysfunctions. Eur Rev Med Pharmacol Sci. 2012; 16(2): 270–275.
  44. Courchesne E, Pramparo T, Gazestani VH, et al. The ASD Living Biology: from cell proliferation to clinical phenotype. Mol Psychiatry. 2019; 24(1): 88–107.
  45. Lombardo MV, Eyler L, Pramparo T, et al. Atypical genomic cortical patterning in autism with poor early language outcome. Sci Adv. 2021; 7(36): eabh1663.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl